Phase II study of oral tegafur/uracil and leucovorin plus bevacizumab as a first-line therapy for elderly patients with advanced or metastatic colorectal cancer

Tsunekazu Mizushima, Hiroshi Tamagawa, Chu Matsuda, Kohei Murata, Mutsumi Fukunaga, Hirofumi Ota, Junichi Hasegawa, Masaki Tsujie, Takayuki Fukuzaki, Taishi Hata, Ichiro Takemasa, Masataka Ikeda, Hirofumi Yamamoto, Mitsugu Sekimoto, Riichiro Nezu, Yuichiro Doki, Masaki Mori

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase II study of oral tegafur/uracil and leucovorin plus bevacizumab as a first-line therapy for elderly patients with advanced or metastatic colorectal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences